Literature DB >> 11470149

Three-color flow cytometric assay for the study of the mechanisms of cell-mediated cytotoxicity.

E Derby1, V Reddy, W Kopp, E Nelson, M Baseler, T Sayers, A Malyguine.   

Abstract

Cytotoxic lymphocytes kill tumor or virus-infected target cells utilizing two mechanisms (1) release of lytic granules (containing perforin and granzymes) and (2) Fas ligand (FasL)/Fas or TNF initiated apoptosis. We have examined mechanisms of target cell lysis using a new Flow Cytometric Cytotoxicity Assay (FC Assay). Target cells were labeled with PKH 67 dye. Cell death was estimated by 7-amino-actinomycin (7-AAD) inclusion and annexin V-PE binding. A strong direct correlation has been found between the percentage of dead target cells in the FC Assay and the results of 51Cr release assay when human LAK and CTL were used as a model system. We have shown that both NK and CTL kill tumor cells mostly by granule-mediated mechanisms, as lysis was blocked by a perforin inhibitor Concanamycin A (Folimycin) but was significantly less sensitive to zVAD-FMK caspase inhibition. The FC assay allows accurate measurement of cell-mediated cytotoxicity as individual target cell death is detected directly.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11470149     DOI: 10.1016/s0165-2478(01)00226-7

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  12 in total

1.  Interferon Alpha Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8+ T Cells.

Authors:  Abena K R Kwaa; Chloe A G Talana; Joel N Blankson
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

2.  Expansion of donor-reactive host T cells in primary graft failure after allogeneic hematopoietic SCT following reduced-intensity conditioning.

Authors:  M Koyama; D Hashimoto; K Nagafuji; T Eto; Y Ohno; K Aoyama; H Iwasaki; T Miyamoto; G R Hill; K Akashi; T Teshima
Journal:  Bone Marrow Transplant       Date:  2013-09-09       Impact factor: 5.483

3.  Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection.

Authors:  Thiago Marconi Cardoso; Álvaro Machado; Diego Luiz Costa; Lucas P Carvalho; Adriano Queiroz; Paulo Machado; Phillip Scott; Edgar M Carvalho; Olívia Bacellar
Journal:  Infect Immun       Date:  2014-12-22       Impact factor: 3.441

Review 4.  New flow cytometric assays for monitoring cell-mediated cytotoxicity.

Authors:  Liubov Zaritskaya; Michael R Shurin; Thomas J Sayers; Anatoli M Malyguine
Journal:  Expert Rev Vaccines       Date:  2010-06       Impact factor: 5.217

5.  Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo.

Authors:  David A Horwitz; Stephanie Pan; Jing-Ni Ou; Julie Wang; Maogen Chen; J Dixon Gray; Song Guo Zheng
Journal:  Clin Immunol       Date:  2013-08-20       Impact factor: 3.969

6.  THAP5 is a human cardiac-specific inhibitor of cell cycle that is cleaved by the proapoptotic Omi/HtrA2 protease during cell death.

Authors:  Meenakshi P Balakrishnan; Lucia Cilenti; Zineb Mashak; Paiyal Popat; Emad S Alnemri; Antonis S Zervos
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-05       Impact factor: 4.733

7.  CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists.

Authors:  Joselín Hernández-Ruiz; Norma Salaiza-Suazo; Georgina Carrada; Sofía Escoto; Adriana Ruiz-Remigio; Yvonne Rosenstein; Alejandro Zentella; Ingeborg Becker
Journal:  PLoS Negl Trop Dis       Date:  2010-11-02

8.  Cytotoxic Efficiency of Human CD8+ T Cell Memory Subtypes.

Authors:  Arne Knörck; Gertrud Schäfer; Dalia Alansary; Josephine Richter; Lorenz Thurner; Markus Hoth; Eva C Schwarz
Journal:  Front Immunol       Date:  2022-04-13       Impact factor: 8.786

9.  Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease.

Authors:  Mark A Vickers; Gwen M Wilkie; Nicolas Robinson; Nadja Rivera; Tanzina Haque; Dorothy H Crawford; Jacqueline Barry; Neil Fraser; David M Turner; Victoria Robertson; Phil Dyer; Peter Flanagan; Helen R Newlands; John Campbell; Marc L Turner
Journal:  Br J Haematol       Date:  2014-07-26       Impact factor: 6.998

10.  Combined treatment of murine fibrosarcoma with chemotherapy (Paclitaxel), radiotherapy, and intratumoral injection of dendritic cells.

Authors:  Ji-Won Byun; Hyeon-Sook Lee; Sun-Uk Song; Si-Won Lee; Soon-Ki Kim; Woo-Chul Kim; Moon-Hee Lee; Gwang-Seong Choi
Journal:  Ann Dermatol       Date:  2014-02-17       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.